Kiryat Motzkin, Israel

Yaron Barac

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yaron Barac: Innovator in Renal and Cardiovascular Treatments

Introduction

Yaron Barac is a notable inventor based in Kiryat Motzkin, Israel. He has made significant contributions to the fields of renal and cardiovascular health through his innovative patents. With a total of 2 patents, Barac's work focuses on methods that address critical health issues.

Latest Patents

Barac's latest patents include groundbreaking methods for the treatment of renal failure. His first patent involves propargylamine and its derivatives, specifically N-propargyl-1-aminoindan and its analogs. These compounds are designed for administration to subjects at high risk for or suffering from acute renal failure (ARF). Additionally, he has developed methods for treating cardiovascular disorders and diseases. This patent also utilizes propargylamine and its derivatives, including N-propargyl-1-aminoindan, enantiomers, and analogs, which are beneficial for the prevention or treatment of various cardiovascular conditions.

Career Highlights

Throughout his career, Yaron Barac has worked with esteemed organizations such as the Technion Research & Development Foundation Limited and the Rappaport Family Institute. His experience in these institutions has allowed him to advance his research and contribute to significant medical innovations.

Collaborations

Barac has collaborated with notable colleagues, including Ofer Binah and Zaid Abassi. These partnerships have further enriched his research and development efforts in the medical field.

Conclusion

Yaron Barac's contributions to renal and cardiovascular treatments through his patents highlight his role as an influential inventor. His innovative methods have the potential to improve the lives of many individuals facing serious health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…